Dean Mid Cap Value Fund (DALCX)

Fund Assets	259.77M
Expense Ratio	0.858%
Min. Investment	$1,000
Turnover	31.00%
Dividend (ttm)	0.27
Dividend Yield	0.90%
Dividend Growth	21.11%
Payout Frequency	Annual
Ex-Dividend Date	Dec 11, 2025

Previous Close	30.27
YTD Return	14.40%
1-Year Return	16.89%
5-Year Return	65.27%
52-Week Low	26.46
52-Week High	31.33
Beta (5Y)	0.74
Holdings	58
Inception Date	May 28, 1997

About DALCX

Dean Mid Cap Value Fund is a mutual fund focused on mid-capitalization U.S. equities. The fund seeks to achieve long-term capital appreciation and, secondarily, dividend income by investing primarily in companies with market capitalizations broadly aligned with those in the Russell Midcap Value Index, typically ranging from approximately $3.5 billion to $40 billion. Its management team employs a disciplined, fundamental, bottom-up research process, using multi-factored valuation techniques such as normalized earnings, discounted cash flows, and key financial ratios to identify businesses perceived as undervalued or overlooked by the market. The investment strategy targets companies that may be temporarily out of market favor, holding positions until valuations better reflect the companies’ fair values. The portfolio is generally composed of 40 to 60 holdings and maintains a diversified approach with strict sector and security concentration guidelines, as well as limited foreign and cash exposure. The fund's approach aims to both exploit market inefficiencies and provide downside protection in challenging environments, contributing to its role as a value-oriented option within the mid-cap segment of the equity market.

• Fund Family: Dean Fund
• Category: Mid-Cap Value
• Performance Rating: Above Average
• Risk Rating: Below Average
• Stock Exchange: Nasdaq
• Ticker Symbol: DALCX
• Index: Russell MidCap Value TR

Performance

DALCX had a total return of 16.89% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.34%.

Top 10 Holdings

23.83% of assets

Name	Symbol	Weight
Jazz Pharmaceuticals plc	JAZZ	3.36%
The Bank of New York Mellon Corporation	BNY	2.77%
Cognizant Technology Solutions Corporation	CTSH	2.43%
Raymond James Financial, Inc.	RJF	2.29%
Encompass Health Corporation	EHC	2.23%
Arrow Electronics, Inc.	ARW	2.21%
Assurant, Inc.	AIZ	2.16%
SS&C Technologies Holdings, Inc.	SSNC	2.15%
Reinsurance Group of America, Incorporated	RGA	2.12%
Ameren Corporation	AEE	2.11%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 11, 2025	$1.632	Dec 12, 2025
Dec 12, 2024	$1.8537	Dec 12, 2024
Dec 12, 2023	$1.2755	Dec 13, 2023
Dec 13, 2022	$1.1842	Dec 14, 2022
Dec 13, 2021	$1.318	Dec 14, 2021
Dec 11, 2020	$0.17557	Dec 11, 2020

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error